Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,780 | 3,100 | 2,260 | 1,650 | 2,470 |
| TOTAL | $1,780 | $3,100 | $2,260 | $1,650 | $2,470 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 5,390 | 5,710 | 6,500 | 5,760 | 5,630 |
| TOTAL | $5,390 | $5,710 | $6,500 | $5,760 | $5,630 |
| Total Assets | $7,170 | $8,810 | $8,760 | $7,410 | $8,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 750 | 700 | 1,070 | 830 | 1,050 |
| Accrued Expenses | 5,900 | 5,430 | 5,050 | 3,950 | 4,910 |
| Other current liabilities | 470 | 860 | 350 | 450 | 520 |
| TOTAL | $7,920 | $7,830 | $7,360 | $6,190 | $7,540 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,080 | 3,030 | 1,660 | 1,650 | 1,670 |
| TOTAL | $4,210 | $4,350 | $2,910 | $3,080 | $3,420 |
| Total Liabilities | $12,130 | $12,180 | $10,270 | $9,270 | $10,960 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Other shareholders' equity | 4,540 | -140 | 80 | -310 | -60 |
| TOTAL | $203,040 | $199,410 | $199,480 | $198,270 | $198,340 |
| Total Liabilities And Equity | $215,170 | $211,590 | $209,750 | $207,540 | $209,300 |